Cannabis as Medicine

21 July 2017 University of Queensland researchers are concerned the recent legalisation of medicinal cannabis in Australia may give rise to super-potent cannabis concentrates with associated harmful effects. UQ Centre for Youth Substance Abuse Research’s Dr Gary Chan, who led the butane hash oil study, said a significant proportion of cannabis users used the concentrate. […]

Uncovering the therapeutic potential of CBD New research paves the way for a new schizophrenia treatment, by testing the effect of a cannabis compound on rats. The study suggests that the cannabis-derived substance may improve schizophrenia-specific cognitive impairment, with none of the side effects that current medication has…CBD can affect learning, memory, and attention, which

13 May 2017 ‘’False hope’’ driving claims medicinal cannabis is ‘’magic pill’’ for chronic pain relief. Prescribing medicinal cannabis for patients with chronic non-cancer pain is not going to revolutionise their treatment and should not be supported until there is substantial proof of its effectiveness, according to a leading pain specialist. Professor Milton Cohen is

Written by Honor Whiteman Published:19 April 2017 For individuals with a severe form of epilepsy, a new study finds that the occurrence of seizures could be significantly reduced with a daily dose of cannabidiol – a chemical component of cannabis.Researchers say that cannabidiol – an active chemical in cannabis – could help to reduce seizures for patients

Written by Honor Whiteman Increased legalization of marijuana for medical purposes may be fueling illicit use of the drug, as well as increasing the number marijuana use disorders, according to the results of a new study.Researchers have identified a greater increase in illicit marijuana use and disorders in states that have legalized medical marijuana. An analysis

Deborah S. Hasin, PhD1,2,3; Aaron L. Sarvet, MPH1,2; Magdalena Cerdá, DrPH4; et alKatherine M. Keyes, PhD1,3; Malka Stohl, MS2; Sandro Galea, MD, DrPH5; Melanie M. Wall, PhD1,2,6 JAMA Psychiatry. Published online April 26, 2017. doi:10.1001/jamapsychiatry.2017.0724 Question  Are US state medical marijuana laws one of the underlying factors for increases in risk for adult cannabis use and cannabis use disorders seen since the early 1990s? Findings  In this analysis using US national survey data collected in 1991-1992, 2001-2002, and

Valdeolivas S1,2,3, Sagredo O4,5,6, Delgado M7,8, Pozo MA9,10, Fernández-Ruiz J11,12,13. Author information Abstract Several cannabinoids afforded neuroprotection in experimental models of Huntington’s disease (HD). We investigated whether a 1:1 combination of botanical extracts enriched in either ∆⁸-tetrahydrocannabinol (∆⁸-THC) or cannabidiol (CBD), which are the main constituents of the cannabis-based medicine Sativex®, is beneficial in R6/2 mice (a transgenic model

Rossignoli MT1, Lopes-Aguiar C2, Ruggiero RN3, Do Val da Silva RA4, Bueno-Junior LS5, Kandratavicius L6, Peixoto-Santos JE7, Crippa JA8, Cecilio Hallak JE9, Zuardi AW10, Szawka RE11, Anselmo-Franci J12, Leite JP13, Romcy-Pereira RN14. Abstract The prefrontal cortex (PFC), amygdala and hippocampus display a coordinated activity during acquisition of associative fear memories. Evidence indicates that PFC engagement in aversive memory formation does not progress linearly as previously thought. Instead, it

Naftali T1,2, Mechulam R3,4, Marii A5, Gabay G6,7, Stein A6,7, Bronshtain M6,7, Laish I6,7, Benjaminov F6,7, Konikoff FM6,7. Author information Abstract BACKGROUND: Cannabidiol (CBD) is an anti-inflammatory cannabinoid shown to be beneficial in a mouse model of IBD. Lacking any central effect, cannabidiol is an attractive option for treating inflammatory diseases. AIM: To assess the effects of cannabidiol on Crohn’s disease in a randomized placebo-controlled

“Citizens Commission on Human Rights International is opposing the world-first study that could lead to millions of Australian and American teens being doped with prescribed marijuana.” By CCHR International The Mental Health Industry Watchdog March 15, 2017 Australian psychiatrist Patrick McGorry, renowned for his debunked and dangerous theory that pre-drugging adolescents with antipsychotics can prevent